How to Give a Safe Intramuscular Shot in the Hip

A safe intramuscular injection in the hip means choosing the ventrogluteal site, which sits on the side of the hip rather than the upper-outer buttock most people picture. A systematic review and meta-analysis comparing the two gluteal sites found that injections at the ventrogluteal site produced less pain, less bleeding, and fewer bruises than injections at the traditional dorsogluteal (upper buttock) site.¹ Yet the ventrogluteal site remains underused, largely because many healthcare workers were never trained on it. Understanding why it is safer and how to locate it makes all the difference.

Why the Ventrogluteal Site Beats the Traditional Buttock

When most people say “a shot in the hip,” they mean the upper-outer quadrant of the buttock, known clinically as the dorsogluteal site. That site was the default for decades, but it carries a real drawback: the sciatic nerve runs through the area, and the gluteal artery is nearby. Nerve injury from intramuscular injection is a recognized complication, and the sciatic nerve is the most frequently affected nerve, particularly in children, elderly patients, and underweight individuals. The damage can range from brief pain to lasting sensory problems and muscle weakness.²

The ventrogluteal site avoids these risks. It sits over the gluteus medius and minimus muscles on the side of the hip, away from major nerves and large blood vessels. The muscle layer there is thick and consistent across body types, and the overlying fat tends to be thinner than at the dorsogluteal site, which means the medication is more likely to reach muscle rather than getting deposited in fat. In older adults, for example, average muscle thickness at the ventrogluteal site was about 40 mm compared to roughly 26 mm at the dorsogluteal site, while subcutaneous fat was thinner at the ventrogluteal site as well.³

Despite these advantages, surveys of nurses consistently find that most still default to the dorsogluteal site. The main reasons are habit, difficulty locating the ventrogluteal landmarks, and a belief that the traditional site is safe enough.⁴ Qualitative research with nurses confirmed that sticking with the familiar method, concerns about patient comfort, and inexperience with the newer site all contribute to the reluctance to switch.⁵ The evidence, though, clearly favors the ventrogluteal site for safety and comfort.

How to Find the Ventrogluteal Site

Locating the ventrogluteal site accurately is the single most important step. The landmark technique uses the bony anatomy of the hip to guide your hand to the right spot, so you do not have to guess.

If you are injecting the patient’s right hip, place the heel of your left hand on the greater trochanter, the bony knob you can feel on the outside of the upper thigh when the patient is lying on their side. Point your index finger toward the front of the hip, aiming for the anterior superior iliac spine, the bony point at the front of the pelvis. Spread your middle finger back toward the iliac crest, the curved ridge of the hip bone you can feel along the top of the pelvis. The triangle formed between your two fingers and the iliac crest is the injection zone. You will inject into the center of that triangle. If you are injecting the left hip, use your right hand and reverse the process.

This hand-placement method exists because simply eyeballing the side of the hip is unreliable. Research on successful gluteal injections found that using anatomical landmarks to select the injection site was strongly associated with the medication actually reaching the muscle.⁶ Skipping the landmark step and going by feel alone is one of the most common reasons an injection ends up in subcutaneous fat instead of muscle.

Choosing the Right Needle

Getting the medication into muscle rather than fat depends heavily on needle length, and the right length depends on the patient’s body size. A needle that is too short deposits the drug into subcutaneous tissue, where absorption is slower and more erratic. A needle that is too long risks hitting bone or deep structures, though that is less common at the ventrogluteal site because of its generous muscle depth.

For the ventrogluteal site specifically, research using imaging to measure tissue layers found that a standard 32 mm (roughly 1.25 inch) needle works for all males and for normal-weight females. A 38 mm (1.5 inch) needle is needed for all females at the ventrogluteal site and for all males at the dorsogluteal site to reliably reach muscle.⁷

Body mass index matters even more than those general guidelines suggest. A separate study measuring subcutaneous fat thickness at the ventrogluteal site found that a standard 1.5-inch needle fails to reach muscle in about seven out of ten women with a BMI above 30 and in about six out of ten men with a BMI above 35.⁸ For patients in those weight ranges, a longer needle or an alternative site like the vastus lateralis (outer thigh) may be necessary. If you are giving injections at home and your provider has not specified a needle length, ask, because this is not a one-size-fits-all situation.

Needle gauge, which refers to the thickness of the needle, is a separate choice. Most intramuscular injections use a 21 to 23 gauge needle. Thinner needles (higher gauge numbers) cause less pain on entry but make it harder to push thicker medications through. For typical vaccines and water-based medications, a 23 gauge needle works well. Oil-based medications like testosterone or certain hormonal injections often require a 21 gauge needle because the liquid is too viscous for thinner ones.

Step-by-Step Injection Technique

Once you have identified the ventrogluteal site and selected the right needle, the actual injection follows a straightforward sequence. Clean the skin with an alcohol swab and let it air-dry completely. Injecting through wet alcohol stings and can carry surface contaminants into the tissue.

Hold the syringe like a dart, perpendicular to the skin at a 90-degree angle. Spread the skin taut with your nondominant hand to stabilize the tissue and reduce discomfort. Insert the needle with a quick, confident motion. Research on injection success rates found that quick needle insertion was significantly associated with the medication reaching the muscle, while hesitant or slow insertion was linked to poorer outcomes.⁶

Push the plunger at a steady, moderate pace. Injecting too fast increases pressure in the tissue and causes more pain. Once the syringe is empty, withdraw the needle smoothly and apply gentle pressure to the site with a cotton ball or gauze. Do not massage the area, as this can push medication back up through the needle track and into the subcutaneous tissue.

The Z-Track Method

The Z-track technique adds one extra step that helps keep medication from leaking back out of the muscle. Before inserting the needle, use your nondominant hand to pull the skin and subcutaneous tissue laterally, about 2 to 3 centimeters to one side. Insert the needle and inject normally while holding the skin displaced. After withdrawing the needle, release the skin. The tissue layers slide back into their natural position, creating a zigzag path that seals the needle track. A study of Z-track injections with an intramuscular pain medication found that the technique reduced drug leakage at the injection site.⁹ The Z-track method is especially useful for medications that stain or irritate tissue, like iron dextran or hydroxyzine.

To Aspirate or Not

Aspiration means pulling back on the plunger for a few seconds after inserting the needle to check for blood, which would indicate the needle tip is inside a blood vessel. This used to be standard practice for every intramuscular injection, and many nursing textbooks still teach it. The evidence, though, has shifted. A systematic review of the literature concluded that aspiration is unnecessary when using the deltoid, ventrogluteal, or vastus lateralis sites, because no major blood vessels are close enough to be a realistic concern at those locations.¹⁰ The same review recommended that aspiration should still be performed when injecting at the dorsogluteal site because of its proximity to the gluteal artery.

That said, aspiration remains part of many institutional guidelines and nursing curricula.¹¹ If your training or your healthcare provider’s instructions include aspiration, follow them. The practical effect of skipping aspiration at the ventrogluteal site is one less painful step for the patient and a faster procedure, but it is not wrong to aspirate if that is your protocol.

Making It Hurt Less

Pain is the number-one reason patients dread intramuscular injections, and several simple techniques can reduce it. A systematic review and meta-analysis of pain-reduction methods found that applying manual pressure to the injection site before the needle goes in was effective, as was Helfer skin tapping, a rhythmic tapping of the skin near the injection site performed just before and during the injection.¹²

The manual pressure approach is easy to do at home. Press firmly on the injection site with your thumb or finger for about ten seconds before swabbing and injecting. One study found that this simple step dropped average pain scores by more than a third compared to no pressure.¹³ The mechanism is straightforward: firm pressure activates large sensory nerve fibers that compete with pain signals, effectively turning down the volume on the sharp sensation of the needle.

Other practical tips that do not require any special equipment:

• Relax the muscle: A tense muscle hurts more to inject into. If the patient is lying on the side opposite the injection, have them bend the top knee slightly and let the hip relax forward. Some practitioners ask the patient to wiggle their toes on the same side, which reflexively loosens the gluteal muscles.
• Warm the medication: Cold injections are more painful. Rolling the syringe between your palms for 30 to 60 seconds brings it closer to body temperature.
• Distract the patient: Conversation, deep breathing, or asking them to cough at the moment of insertion all help redirect attention away from the needle.

Acupressure-based techniques, which involve applying sustained and then intermittent pressure to specific points near the injection site, also showed strong pain-reducing effects in the same meta-analysis. However, those techniques require training to perform correctly and are less practical for home caregivers.

Complications and How to Prevent Them

Serious complications from intramuscular injections in the hip are uncommon when the ventrogluteal site is used correctly, but knowing what can go wrong helps you act quickly if something seems off.

• Sciatic nerve injury: This is the most feared complication and is almost exclusively associated with the dorsogluteal site. A review of injection-related nerve injuries noted that pain is often the earliest symptom, but it can mask underlying nerve damage that affects sensation or movement in the leg.¹⁴ If a patient reports shooting pain down the back of their leg during or after a buttock injection, or develops foot drop or numbness in the days that follow, seek medical attention immediately. Using the ventrogluteal site essentially eliminates this risk.
• Subcutaneous deposition: When the needle is too short for the patient’s body type, the medication ends up in the fat layer rather than the muscle. The drug absorbs more slowly and unpredictably, which matters most for time-sensitive medications. This is not an emergency, but it means the dose may not work as intended.
• Infection: Any break in the skin can introduce bacteria. Proper skin cleaning and using a fresh, sterile needle each time are the basics. Redness, swelling, warmth, or increasing pain at the injection site in the hours or days after an injection can signal an abscess forming.
• Hematoma: A bruise under the skin that develops from hitting a small blood vessel. It is more common at the dorsogluteal site. Applying gentle pressure after withdrawing the needle helps reduce this.

The common thread is that most complications are preventable by choosing the ventrogluteal site, using the right needle length, and following proper technique. The ventrogluteal site’s lower rates of pain, bleeding, and hematoma compared to the dorsogluteal site are not marginal differences; the meta-analysis comparing the two sites found statistically significant reductions across all three outcomes.¹

Children, Older Adults, and Higher Body Weight

The ventrogluteal site works across a broader range of body types than many people expect, but each population has its quirks.

For young children, the ventrogluteal site has historically been avoided in favor of the vastus lateralis (outer thigh), partly because clinicians assumed children’s hip muscles were too small. An ultrasound study of children aged 36 months and younger found that the ventrogluteal site actually had adequate muscle thickness for intramuscular injection across all age groups studied, and that its muscle was thicker than the deltoid’s.¹⁵ The vastus lateralis remains the most commonly recommended site for infant vaccinations because it is easy to access and well-studied, but the ventrogluteal site is a viable alternative when the thigh is not an option.

For older adults, the ventrogluteal site is arguably even more important. Age-related muscle loss tends to thin the dorsogluteal muscles substantially, while the ventrogluteal muscles hold up better. As noted earlier, imaging in older adults showed the ventrogluteal site had about 60 percent more muscle thickness than the dorsogluteal site.³ Thinner muscle at the dorsogluteal site means a standard needle is more likely to overshoot into deeper tissue or deposit medication into fat, both of which are worse outcomes.

Body weight introduces the biggest variable in needle selection. The failure rates for a standard 1.5-inch needle at the ventrogluteal site in patients with higher BMI are striking: roughly 71 percent failure in women above a BMI of 30 and 60 percent in men above a BMI of 35.⁸ “Failure” here means the medication never reaches the muscle. If you or the person you are injecting has a higher BMI, a 2-inch needle or an alternative site should be discussed with a healthcare provider. The outer thigh (vastus lateralis) is the usual backup, because subcutaneous fat tends to be thinner there, and cadaver studies have confirmed no major blood vessels or nerves at the standard injection point on the outer thigh.¹⁶

Needle Safety and Disposal

If you are giving injections at home, proper sharps disposal is a legal requirement in most places and a basic safety measure for everyone in the household. Used needles go into a puncture-resistant sharps container immediately after use, never into regular trash, recycling, or loose in a bag. When the container is about three-quarters full, seal it and follow your local guidelines for disposal; many pharmacies and waste facilities accept sharps containers.

Safety-engineered syringes, which have built-in mechanisms that shield or retract the needle after use, reduce needlestick injuries by roughly half compared to standard syringes. A meta-analysis of sharp injury prevention devices found a pooled risk reduction of about 46 percent for needlestick injuries among healthcare workers using these devices.¹⁷ If you are giving injections frequently at home, ask your pharmacy whether safety syringes are available for your medication. They cost slightly more but eliminate the riskiest moment in the process: recapping or handling the exposed needle after the injection is done.

Never bend, break, or recap a used needle by hand. If you absolutely must recap for transport to a sharps container, use the one-handed scoop technique: lay the cap on a flat surface, slide the needle tip into it, then press down to snap the cap on. Both hands should never be near the needle tip at the same time.